Table 3 Serious adverse events following HPV vaccination
From: Answering human papillomavirus vaccine concerns; a matter of science and time
Study | % vaccine | % control | Relative risk (95% CI) |
|---|---|---|---|
Future I | 1.8 | 1.7 | 1.07 (0.71-1.60) |
Future II | 0.7 | 0.9 | 0.83 (0.56-1.24) |
Harper | 4.1 | 3.5 | 1.17 (0.64-2.14) |
Koutsky | 0.3 | 0.3 | 1.34 (0.30-5.96) |
Munoz | 0.2 | 0.4 | 0.43 (0.11-1.65) |
Villa | 0.7 | 0.7 | 1.01 (0.14-7.10) |
PATRICIA | 7.5 | 7.5 | 1.00 (0.91-1.11) |
Total | 1.00 (0.91-1.09) | ||